Literature DB >> 2285289

Mathematical modeling of antimicrobial susceptibility data of Staphylococcus haemolyticus for 11 antimicrobial agents, including three experimental glycopeptides and an experimental lipoglycopeptide.

P R Hunter1, R C George, J W Griffiths.   

Abstract

Antimicrobial MIC data were obtained for 96 strains of Staphylococcus haemolyticus and the following 11 antimicrobial agents: methicillin, gentamicin, rifampin, fusidic acid, ciprofloxacin, vancomycin, teicoplanin; three experimental glycopeptides, MDL 62,873, MDL 62,208, and MDL 62,224; and an experimental lipoglycopeptide, ramoplanin. Resistance to methicillin and gentamicin was present in over 50% of the strains, although resistance to the other agents was present in less than 10%. It is shown how application of mathematical modeling techniques can add to the understanding of such MIC data. MICs of methicillin and gentamicin were highly correlated, suggesting that evolutionary pressures for development of resistance to these agents were similar. The structural relationships among the glycopeptides were accurately reflected in their spatial relationships within the model. MICs of ramoplanin were negatively correlated with MICs of some other antimicrobial agents, particularly gentamicin, suggesting that this agent is more active against gentamicin-resistant strains. Methicillin-resistant strains were more tightly clustered than were methicillin-susceptible strains, suggesting that methicillin-resistant strains were more closely related to each other than were methicillin-susceptible strains. Mathematical modeling techniques enable more detailed analysis of MIC data.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285289      PMCID: PMC171921          DOI: 10.1128/AAC.34.9.1769

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Emergence of vancomycin resistance in coagulase-negative staphylococci.

Authors:  R S Schwalbe; J T Stapleton; P H Gilligan
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

2.  Ivestigation of coagulase-negative staphylococci from infections in surgical patients.

Authors:  R R Marples; R Hone; C M Notley; J F Richardson; J A Crees-Morris
Journal:  Zentralbl Bakteriol Orig A       Date:  1978-07

3.  Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics. Structure-activity relationships.

Authors:  A Malabarba; A Trani; P Strazzolini; G Cietto; P Ferrari; G Tarzia; R Pallanza; M Berti
Journal:  J Med Chem       Date:  1989-11       Impact factor: 7.446

4.  Species identification and susceptibility to 17 antibiotics of coagulase-negative staphylococci isolated from clinical specimens.

Authors:  F J Marsik; S Brake
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

5.  Species identification of coagulase-negative staphylococcal isolates from blood cultures.

Authors:  R H Eng; C Wang; A Person; T E Kiehn; D Armstrong
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

6.  Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus.

Authors:  J W Froggatt; J L Johnston; D W Galetto; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

7.  Antimicrobial resistance in coagulase-negative staphylococci.

Authors:  J M Hamilton-Miller; A Iliffe
Journal:  J Med Microbiol       Date:  1985-04       Impact factor: 2.472

8.  Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis.

Authors:  L D Gruer; R Bartlett; G A Ayliffe
Journal:  J Antimicrob Chemother       Date:  1984-06       Impact factor: 5.790

  8 in total
  7 in total

1.  In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.

Authors:  F Biavasco; R Lupidi; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections.

Authors:  M Berti; G Candiani; M Borgonovi; P Landini; F Ripamonti; R Scotti; L Cavenaghi; M Denaro; B P Goldstein
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 3.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  Multidimensional analysis for interpreting antibiotic susceptibility data.

Authors:  M R Scavizzi; A Elbhar; J P Fénelon; F D Bronner
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  Use of multivariate analysis to compare antimicrobial agents on the basis of in vitro activity data.

Authors:  J M Hernández; P Conforti
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

6.  Emergence of teicoplanin-resistant coagulase-negative staphylococci.

Authors:  E Cercenado; M E García-Leoni; M D Díaz; C Sánchez-Carrillo; P Catalán; J C De Quirós; E Bouza
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

7.  Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States.

Authors:  R N Jones; F W Goldstein; X Y Zhou
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.